I-125 Ophthalmic Seeds Individual Eye Tumor Treatment Eckert & Ziegler BEBIG’s Ophthalmic Seed is the IsoSeed® I-125 (I25.S16) with a particularly high activity for eye tumor treatments. IsoSeed® I25.S16 is used for the treatment of eye tumors, such as uveal melanomas and retinoblastomas. With apparent activities covering a wide range up to 25 mCi, it is even suitable for treating medium-sized to large eye tumors, opening up treatment options beyond Ru-106 Eye Applicators. The certified source strength is based on air kerma measurements of IsoSeed® which are traceable to the primary standard of the PTB (Physikalisch-Technische Bundesanstalt = National Metrology Institute of Germany). Along with the NIST (National Institute of Standards and Technology), the PTB is a member of the Mutual Recognition Agreement. Application IsoSeeds® I25.S16 are delivered non-sterile. For application, they can be inserted into Plaque Shells. After steam sterilization, the individually assembled Applicator is ready for u

Guaranteed Biocompatibility The titanium capsule of IsoSeed® I25.S16 meets ASTM F67 requirements to ensure biocompatibility of Eckert & Ziegler BEBIG Ophthalmic Seeds. „Made in Germany" Quality The Ophthalmic Seeds are manufactured in Germany in compliance with strict quality standards. Each single item has to pass an individual quality check at every production stage before proceeding to the next step. Eckert & Ziegler BEBIG is certified in accordance with ISO 13485. Source Strength The air kerma strength of every IsoSeed® I25.S16 is measured individually and converted into apparent activity....